Psychiatry News

Individuals who required hospital-based care for cannabis use disorder faced nearly three times the risk for premature death, results from a cohort analysis published in JAMA Network Open showed.

Less than 7% of individuals with mental health or substance use disorders receive effective treatment worldwide, according to a cross-sectional analysis published in JAMA Psychiatry.

Antidepressants were more effective than placebo in reducing anxiety symptoms among adults with moderate to severe generalized anxiety disorder, according to a review published in Cochrane Database of Systematic Reviews.

The rates of fatal drug overdoses stayed higher than expected in most states from 2020 to 2023 compared with trajectories before 2020, a cross-sectional analysis in JAMA Network Open showed.

An AI model demonstrated efficacy at identifying moderate to severe depression through speech patterns, according to a cross-sectional analysis published in Annals of Family Medicine.

Many mental health care clinicians screen for firearm access and are confident in their ability to implement such screening, a research letter in JAMA Network Open showed.

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after cannabis legalization, according to a study published in JAMA Network Open.

LinusBio last week announced the launch of a diagnostic aid designed to help clinicians rule out autism in children aged 1 to 36 months using a single strand of hair.

Heavy use of cannabis recently or at any point in a person’s lifetime was tied to decreases in brain function during a working memory task, a new cross-sectional analysis showed.